Abcam, ab269489, Human TREM2 knockout THP-1 cell line

Size: 2 x 1000000Cells / vial / 1000000Cells / vial
Human TREM2 knockout THP-1 cell line (ab269489) available to order. Recommended control: Human wild-type THP-1 cell line (ab271147). - TREM2 KO validation: Next Generation Sequencing (NGS), Western blot - Concentration: 1 million cells/vial
Key facts
Cell type:THP-1,
Species or organism:Human,
Tissue:Blood,
Form:LiquidSee storage information,
Knockout validation:Next Generation Sequencing,Western blot,
Mutation description:Knockout achieved by CRISPR/Cas9; X = 1 bp deletion, 2 bp deletion; Frameshift: 97%,
Disease:Acute Monocytic Leukemia

Product details:
We will provide viable cells that proliferate on revival.
This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our
limited use license
patent pages

Properties and Storage Information:
Gene name-TREM2, Gene editing type-Knockout, Gene editing method-CRISPR technology, Knockout validation-Next Generation Sequencing, Western blot, Shipped at conditions-Dry Ice, Appropriate short-term storage conditions--196°C, Appropriate long-term storage conditions--196°C